Exicure (XCUR) Capital Expenditures Growth (1y) (2017 - 2022)
Exicure (XCUR) Capital Expenditures Growth (1y) (2017 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Exicure |
19.38 Mn |
16.77 Mn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2022 |
-98.82% |
| Mar 31, 2022 |
-97.33% |
| Dec 31, 2021 |
111.38% |
| Sep 30, 2021 |
-98.04% |
| Jun 30, 2021 |
165.57% |
| Mar 31, 2021 |
-61.01% |
| Dec 31, 2020 |
-507.94% |
| Sep 30, 2020 |
988.09% |
| Jun 30, 2020 |
-1,057.41% |
| Mar 31, 2020 |
7,112.50% |
| Dec 31, 2019 |
1,403.51% |
| Sep 30, 2019 |
5,440.00% |
| Jun 30, 2019 |
260.00% |
| Mar 31, 2019 |
-82.22% |
| Dec 31, 2018 |
-128.50% |
| Jun 30, 2018 |
-75.81% |
| Mar 31, 2018 |
-81.63% |
| Dec 31, 2017 |
165.79% |
